NSN 6505-01-278-1124 NDC00015309145, NDC00015-3091-45, VEPESID
Product Details | ETOPOSIDE CAPSULES
6505-01-278-1124 00001016505000000
Part Alternates: NDC00015309145, NDC00015-3091-45, VEPESID, VEPESID 50 MG CAPSULAS , VEPESID CAPSULES, VEPESID50MGCAPSULAS, VEPESIDCAPSULES, 309145, 3091-45, 6505-01-278-1124, 01-278-1124, 6505012781124, 012781124
Medical, Dental, and Veterinary Equipment and Supplies | Drugs and Biologicals
| Supply Group (FSG) | NSN Assign. | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | 30 APR 1988 | 01-278-1124 | 47750 ( ETOPOSIDE CAPSULES0 ) |
Cross Reference | NSN 6505-01-278-1124
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 3091-45 | 29398 | MEAD JOHNSON & COMPANY, LLC DBA MEAD JOHNSON NUTRITIONALS |
| NDC00015-3091-45 | 29398 | MEAD JOHNSON & COMPANY, LLC DBA MEAD JOHNSON NUTRITIONALS |
| VEPESID | 29398 | MEAD JOHNSON & COMPANY, LLC DBA MEAD JOHNSON NUTRITIONALS |
| VEPESID 50 MG CAPSULAS | 006XK | BRISTOL-MYERS SQUIBB FARMACEUTICA LTDA |
| VEPESID CAPSULES | 29398 | MEAD JOHNSON & COMPANY, LLC DBA MEAD JOHNSON NUTRITIONALS |
Request a Quote
What Our Customers Say
Compare
NSNs for Compare ( up to 4 ): Add 6505-01-278-1124
Related Products | NSN 6505-01-278-1124
Technical Data | NSN 6505-01-278-1124
| Characteristic | Specifications |
|---|---|
| CAPSULE TYPE | ANY ACCEPTABLE |
| CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 50.000 MILLIGRAMS ETOPOSIDE ACTIVE INGREDIENT |
| PRIMARY CONTAINER TYPE | STRIP |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 20.000 |
| UNIT PACKAGE TYPE | PACKAGE |
| FEATURES PROVIDED | INDIVIDUALLY SEALED |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING |
| INTERMEDIATE PACKAGE QUANTITY | 10 |
| EXTERIOR CONTAINER QUANTITY | 240 |
| UNIT OF ISSUE WEIGHT | 0.10 POUNDS |
| EXTERIOR CONTAINER WEIGHT | 28.00 POUNDS |
| UNIT OF ISSUE CUBE | 0.008 CUBIC FEET |
| EXTERIOR CONTAINER CUBIC MEASURE | 1.90 CUBIC FEET |
| III PART NAME ASSIGNED BY CONTROLLING AGENCY | ETOPOSIDE CAPSULES 50MG I.S. 20S PG |
Restrictions/Controls & Freight Information | NSN 6505-01-278-1124
| Category | Code | Description |
|---|---|---|
| Shelf-Life Code: | S | 60 months |
| Hazardous Material Indicator Code | Y | Information is in the Hazardous Materials Information System (HMIS) |
| Demilitarization Code: | A | Non-Munitions List Item/ Non-Strategic List Item - Demilitarization not required. |
| Controlled Inventory Item Code: | U | UNCLASSIFIED |
| Hazardous Control Code: | H1 | Hazard Characteristics Not Yet Determined * HAZ CHAR NOT DETERMINED |
| Precious Metals Indicator Code: | A | Item does not contain precious metal |
| Criticality Code: | X | The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. |
| Category | Code | Description |
|---|---|---|
| No Freight Information | ||
Management | NSN 6505-01-278-1124
| Category | Code | Description |
|---|---|---|
| Cognizance Codes | 9L | Navy-owned stocks of defense medical material Naval Inventory Control Point, Mechanicsburg |
| Source of Supply | S9M | Defense Supply Center Philadelphia Director of Medical Materiel Philadelphia, PA 19145 |
| Agency | DN | Department of the Navy |
| Service Organization | N | U.S. Navy |
| Acquisition Advice Codes | Y | TERMINAL ITEM #(NON-STOCKED ITEMS) Future procurement is not authorized. No wholesale stock is available for issue. 1. Requisitions will not be processed to the wholesale manager. 2. Internal Service/agency requisitioning may be continued in accordance with the Service/agency requisitioning policies. |
| Controlled Item Code | U | UNCLASSIFIED |
| Shelf Life Code | M | 24 months |
| Purchasing | QTY UOM |
1 PG : Package |



